Understanding the neurocognitive heterogeneity in bipolar disorder
了解双相情感障碍的神经认知异质性
基本信息
- 批准号:9493978
- 负责人:
- 金额:$ 44.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-08-01 至 2019-04-30
- 项目状态:已结题
- 来源:
- 关键词:Activities of Daily LivingAcuteAddressAffectiveAffective SymptomsAlcohol or Other Drugs useAnxiety DisordersArchitectureAreaAttentionBiologicalBiological AssayBiological MarkersBipolar DisorderBlood specimenBrain-Derived Neurotrophic FactorCategoriesChild AbuseCircadian RhythmsClinicalClinical MarkersCluster AnalysisCognitiveCommunitiesComorbidityDataData AnalyticsDevelopmental CourseDiagnosticDimensionsDiseaseDisease remissionEtiologyEvaluationFrequenciesFutureHeterogeneityImpaired cognitionImpairmentIndependent LivingIndividualInterleukin-12Interleukin-2MeasuresMediator of activation proteinMedicalModelingNeurocognitionNeurocognitiveNeurocognitive DeficitNeuropsychologyOccupationalOutcomePatientsPatternPeripheralPhenotypePsychotic DisordersQuality of lifeRecording of previous eventsRecoveryResearchRiskRoleSamplingSchizophreniaSeveritiesSleepStructureSubgroupTNF geneTestingVerbal Learningabuse neglectbasecognitive performancecohortcytokinedesigndisabling symptomeffective therapyexecutive functionfunctional disabilityfunctional outcomesinflammatory markerinsightneurotrophic factornovelnovel strategiespediatric traumaperformance testspublic health relevancesocialtrait
项目摘要
DESCRIPTION (provided by applicant): Patients with bipolar disorder (BPD) were once thought to achieve complete inter-episode recovery, particularly with regard to cognitive dysfunction. More recent data suggest a persistent, trait-like pattern of neurocognitive impairments in BPD, even during periods of affective remission. At the group level, the severity of these deficits is 3/4 to 1 full standard deviation below average, which is significantly less severe than deficits noted in schizophrenia (SZ). Recent evidence, however, suggests that the frequency of cognitive impairment in euthymic BPD patients is ~40-60%, with a substantial proportion of patients characterized as cognitively- spared. This contrasts with the relative homogeneity of this phenotype in SZ where > 90% of patients demonstrates significant impairment. A better understanding of the cognitive heterogeneity in BPD, why some patients develop significant cognitive difficulties while others do not, is critical toward optimizing patiets' quality of life. The current proposal aims to determine the clinical and biological predictors of cognitive impairment in 350 patients with BPD using a novel approach. We will empirically test for homogeneous subgroups within the sample based neurocognitive performance and test a cassette of clinical features and biomarkers as potential predictors of impairment. We will also investigate the relationship between neurocognitive functioning and everyday functional capacity in the areas of occupational, social and independent living ability. Data will provide important information on the underlying structure of neurocognition in BPD and its etiology, guiding future efforts to target these disabling symptoms with treatment.
描述(由申请人提供):双相情感障碍(BPD)患者曾被认为可以实现完全的发作间恢复,特别是在认知功能障碍方面。最近的数据表明,BPD患者的神经认知障碍具有持续性、特征样模式,即使在情感缓解期间也是如此。在组水平上,这些缺陷的严重程度是低于平均值的3/4至1个完整的标准差,这明显低于精神分裂症(SZ)中观察到的缺陷。然而,最近的证据表明,在心境正常的BPD患者中,认知障碍的频率约为40- 60%,其中相当大比例的患者被表征为认知保留。这与SZ中该表型的相对同质性形成对比,在SZ中> 90%的患者表现出显著的损伤。更好地理解BPD的认知异质性,为什么有些患者会出现明显的认知困难,而另一些患者则不会,这对优化患者的生活质量至关重要。目前的提案旨在使用一种新的方法确定350例BPD患者认知障碍的临床和生物学预测因素。我们将凭经验检验样本中基于神经认知表现的同质亚组,并检验临床特征和生物标志物的盒作为损伤的潜在预测因子。我们还将研究神经认知功能与职业,社会和独立生活能力领域的日常功能能力之间的关系。这些数据将为BPD及其病因学的神经认知基础结构提供重要信息,指导未来针对这些致残症状进行治疗的努力。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
TNF-α and its soluble receptors mediate the relationship between prior severe mood episodes and cognitive dysfunction in euthymic bipolar disorder.
- DOI:10.1016/j.bbi.2020.04.003
- 发表时间:2020-08
- 期刊:
- 影响因子:0
- 作者:Millett CE;Harder J;Locascio JJ;Shanahan M;Santone G;Fichorova RN;Corrigan A;Baecher-Allan C;Burdick KE
- 通讯作者:Burdick KE
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Katherine Elizabeth Burdick其他文献
Katherine Elizabeth Burdick的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Katherine Elizabeth Burdick', 18)}}的其他基金
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage
使用四氢孕酮探讨围绝经期女性抑郁症的行为和神经生物学机制
- 批准号:
10557128 - 财政年份:2022
- 资助金额:
$ 44.38万 - 项目类别:
Using allopregnanolone to probe behavioral and neurobiological mechanisms that underlie depression in women across perimenopausal stage
使用四氢孕酮探讨围绝经期女性抑郁症的行为和神经生物学机制
- 批准号:
10358658 - 财政年份:2022
- 资助金额:
$ 44.38万 - 项目类别:
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders
衰老和情绪障碍中基于大脑的情绪调节机制
- 批准号:
10319173 - 财政年份:2020
- 资助金额:
$ 44.38万 - 项目类别:
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders
衰老和情绪障碍中基于大脑的情绪调节机制
- 批准号:
10154000 - 财政年份:2020
- 资助金额:
$ 44.38万 - 项目类别:
Brain-based Mechanisms of Emotion Regulation in Aging and Mood Disorders
衰老和情绪障碍中基于大脑的情绪调节机制
- 批准号:
10514586 - 财政年份:2020
- 资助金额:
$ 44.38万 - 项目类别:
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach
精神病患者的神经认知异质性_维度方法
- 批准号:
8828502 - 财政年份:2014
- 资助金额:
$ 44.38万 - 项目类别:
1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
1/2-普拉克索治疗双相情感障碍:目标认知 (PRAM-BD)
- 批准号:
8760643 - 财政年份:2014
- 资助金额:
$ 44.38万 - 项目类别:
1/2-Pramipexole in Bipolar Disorder: Targeting Cognition (PRAM-BD)
1/2-普拉克索治疗双相情感障碍:目标认知 (PRAM-BD)
- 批准号:
9070766 - 财政年份:2014
- 资助金额:
$ 44.38万 - 项目类别:
Neurocognitive Heterogeneity in Patients with Psychosis _ A Dimensional Approach
精神病患者的神经认知异质性_维度方法
- 批准号:
8634973 - 财政年份:2014
- 资助金额:
$ 44.38万 - 项目类别:
Understanding the Neurocognitive Heterogeneity in Bipolar Disorder
了解双相情感障碍的神经认知异质性
- 批准号:
8596131 - 财政年份:2013
- 资助金额:
$ 44.38万 - 项目类别:
相似海外基金
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Collaborative R&D
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Fellowship
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Acute human gingivitis systems biology
人类急性牙龈炎系统生物学
- 批准号:
484000 - 财政年份:2023
- 资助金额:
$ 44.38万 - 项目类别:
Operating Grants














{{item.name}}会员




